NURIX THERAPEUTICS, INC. (NRIX) /
The revenue of NURIX THERAPEUTICS, INC. over the past 7 years
Chart NURIX THERAPEUTICS, INC.: revenue, fiscal 2019–2025 Open the chart →NURIX THERAPEUTICS, INC. reported revenue of $83.98M in fiscal 2025, the latest fiscal year on file. In fiscal 2019 it was $31.11M — up 170% over 6 years. Year over year, revenue rose 4 times and fell twice. In these years the lowest $17.82M in fiscal 2020. The largest one-year move was in fiscal 2023: up 99%, from $38.63M to $76.99M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Nov 30, 2025 | $83.98M |
| 2024ended Nov 30, 2024 | $54.55M |
| 2023ended Nov 30, 2023 | $76.99M |
| 2022ended Nov 30, 2022 | $38.63M |
| 2021ended Nov 30, 2021 | $29.75M |
| 2020ended Nov 30, 2020 | $17.82M |
| 2019ended Nov 30, 2019 | $31.11M |
Fiscal years as NURIX THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on NURIX THERAPEUTICS, INC.
- The profitability of NURIX THERAPEUTICS, INC.
- The cash flow of NURIX THERAPEUTICS, INC.
- The debt of NURIX THERAPEUTICS, INC.
- All of NURIX THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- UNFIUnited Natural Foods, Inc.
- DANDana Incorporated
- FLYFirefly Aerospace Inc.
- PTRNPattern Group Inc.
- CUBICustomers Bancorp, Inc.
Not investment advice. This page shows what NURIX THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.